SCHEMBL15411337

SCHEMBL15411337

O=C(Nc1c(F)c(F)c(C(F)(F)F)c(F)c1F)c1ccc(Br)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
DGAT1 O75907 1/20 0.46
GPR27 Q9NS67 1/20 0.44
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
TMPRSS4 Q9NRS4 1/20 0.42
PPARD Q03181 1/20 0.42
GPR35 Q9HC97 1/20 0.39
PTGFR P43088 1/20 0.39
USP30 Q70CQ3 1/20 0.38
TP53 P04637 1/20 0.38
NTRK1 P04629 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15410865 0.83 CYP11B2 (0.49) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL15412101 0.81 ESRRG (0.44) KMT2AGAAGPR27NTRK1MEN1
SCHEMBL15411326 0.81 RXFP1 (0.40) KMT2AALDH1A1SMN1; SMN2NTRK1MEN1
SCHEMBL15410038 0.80 TSHR (0.51) NPC1RAB9AALDH1A1TMPRSS4GPR35
SCHEMBL15411825 0.80 KMT2A (0.52) KMT2AALDH1A1LMNAGAASMN1; SMN2
SCHEMBL15410721 0.80 MEN1 (0.56) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL15410034 0.80 KCNJ11 (0.47) NPC1RAB9AKMT2ALMNATP53
SCHEMBL15410723 0.78 KCNJ11 (0.52) NPC1RAB9AKMT2AALDH1A1GAA
SCHEMBL15410162 0.76 SMN1; SMN2 (0.46) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL3853307 0.76 SMN1; SMN2 (0.70) NPC1RAB9AKMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140018566-A1 PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES THE SCRIPPS RESEARCH INSTITUTE (US) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018566-A1 PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES AHR, DDT, AOC2 NPC1 2304/4885RAB9A 661/4885KMT2A 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.